Last updated on July 2019

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone


Brief description of study

The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo in participants with type 2 diabetes not under control with diet and exercise alone. The study will last approximately 47 weeks and may include about 15 visits.

Clinical Study Identifier: NCT03954834

Find a site near you

Start Over

National Research Institute

Huntington Park, CA United States
  Connect »

National Research Institute

Los Angeles, CA United States
  Connect »

Valley Clinical Trials, Inc.

Northridge, CA United States
  Connect »

National Research Institute

Panorama City, CA United States
  Connect »

Clinical Research of South Florida

Coral Gables, FL United States
  Connect »

iACT Health - Main Location

Columbus, GA United States
  Connect »

Cotton O'Neil Clinic

Topeka, KS United States
  Connect »

Clinical Research Professionals

Chesterfield, MO United States
  Connect »

StudyMetrix Research, LLC

Saint Peters, MO United States
  Connect »

Aventiv Research

Columbus, OH United States
  Connect »

Intend Research

Norman, OK United States
  Connect »

The Corvallis Clinic P.C.

Corvallis, OR United States
  Connect »

Family Medical Associates

Levittown, PA United States
  Connect »

Clinical Trials of Texas, Inc.

San Antonio, TX United States
  Connect »

Consano Clinical Research

Shavano Park, TX United States
  Connect »

Gandhi Hospital

Secunderabad, India
  Connect »

GCM Medical Group PSC

San Juan, Puerto Rico
  Connect »

iACT Health

Columbus, GA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.